This week, GW Pharmaceuticals (NASDAQ: GWPH)had an advisory committee meeting regarding its epilepsy drug Epidiolex, and the results were exciting for both the drug itself and the U.S. medical marijuana industry at large.
A Promising Step for Medical Marijuana
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться